![Alexander Schuth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexander Schuth
Gründer bei DENALI THERAPEUTICS INC.
Vermögen: 11 Mio $ am 31.05.2024
Aktive Positionen von Alexander Schuth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
DENALI THERAPEUTICS INC. | Geschäftsführer | 01.03.2015 | - |
Finanzdirektor/CFO | 01.05.2022 | - | |
Gründer | 14.10.2013 | - | |
Unternehmenssekretär | 01.06.2015 | - | |
Molecular Health GmbH
![]() Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Alexander Schuth
Ehemalige bekannte Positionen von Alexander Schuth
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.08.2005 | 01.03.2015 |
Merrill Lynch International
![]() Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Corporate Officer/Principal | 01.01.2001 | 01.05.2003 |
Posbelduf Biotech AG
![]() Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - |
Ausbildung von Alexander Schuth
Charité - Universitätsmedizin Berlin | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 4 |
Deutschland | 3 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
DENALI THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Merrill Lynch International
![]() Merrill Lynch International Investment Banks/BrokersFinance Merrill Lynch International (MLI-UK) is a brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of ML UK Capital Holdings Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. MLI-UK provides brokerage services to individual and retail clients. | Finance |
Posbelduf Biotech AG
![]() Posbelduf Biotech AG Pharmaceuticals: MajorHealth Technology Molecular Health AG provides clinico-molecular informatic solutions. The firm’s approach allows doctors translate patient-specific molecular and genomic data, clinical history, and published scientific evidence into drug choices. The company was founded by Friedrich von Bohlen in 2004 and is headquartered in Basel, Switzerland. | Health Technology |
Molecular Health GmbH
![]() Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Commercial Services |
- Börse
- Insiders
- Alexander Schuth
- Erfahrung